IT Correspondent,
Mumbai, Feb 25:
A team of Narcotics Control Bureau(NCB) raided a house located in New Delhi and recovered a sizable number of psychotropic drugs stored in contravention of the Drugs and Cosmetics Act, 1940 and Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985 on Wednesday.
The seizure was effected in response to a case (NCB Mumbai Crime No. 16/2021) and Alprazolam tablets, Tramadol tablets and injections and Codeine was recovered from a House No. 39, Sant Nagar, Burari, North Delhi. The seized drugs included: Alprazolam – 2700 tablets Tramadol – 2835 tablets, Tramadol – 100 ampoules injections and Codeine – 6.9 kgs. Further investigation is under progress, NCB Zonal Director Sameer Wankhede told “Imphal Times”.
Tramadol is a psychotropic drug which is medically prescribed as pain killer also. It is a schedule ‘H’ drug under the Drugs and Cosmetics Act, 1940 and can only be dispensed under the prescription of a registered medical practitioner. But over past few years, its abuse as intoxicating drug had been noticed. Due to which it was added to Schedule of psychotropic substances to NDPS Act, 1985 in the year 2018.
Tramadol destined for clandestine markets.
As per a report for 2019, by the International Narcotics Control Board, which falls under the United Nations Office on Drugs and Crime (UNODC), in recent years, India has emerged as the center of manufacturing of Tramadol destined for clandestine markets. India is a significant source of trafficked, falsified, substandard, or illicitly manufactured “Tramadol” that is seized worldwide. For example, 87 percent of the Tramadol seized in Ghana in 2017 came from India, the report stated. It also notes that illicit cultivation of cannabis & ATS drugs is a major problem in the country.
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
